Top 10 Late-Stage Cancer Drugs – 2012

Top 10 Late-Stage Cancer Drugs – 2012 (according to FierceBiotech)

http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/10-promising-late-stage-cancer-drugs-2012

Name	Lead Indication
BBI608	Colorectal cancer	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/bbi608-10-promising-late-stage-cancer-drug
Cabozantinib	Thyroid cancer (but prostate is the big opportunity)	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/cabozantinib-10-promising-late-stage-cance
Carfilzomib	Multiple myeloma	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/carfilzomib-10-promising-late-stage-cancer
Enzalutamide (formerly MDV3100)	Prostate cancer	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/enzalutamide-formerly-mdv3100-10-promising
Ponatinib	Chronic myeloid leukemia	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/ponatinib-10-promising-late-stage-cancer-d
Regorafenib	Filings for approval in colon cancer slated for 2012	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/regorafenib-10-promising-late-stage-cancer
Talimogene laherparepvec (OncoVex)	Melanoma	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/talimogene-laherparepvec-oncovex-10-promis
T-DM1 (trastuzumab emtansine)	Breast cancer	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/t-dm1-trastuzumab-emtansine-10-promising-l
Tivozanib	Renal cell carcinoma	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/tivozanib-10-promising-late-stage-cancer-d
Zaltrap (aflibercept concentrate)	Colorectal cancer	http://www.fiercebiotech.com/special-reports/10-promising-late-stage-cancer-drugs-2012/zaltrap-aflibercept-concentrate-10-promisi